Skip to main content

Table 3 Resource use

From: Intensive care–treated cardiac arrest: a retrospective study on the impact of extended age on mortality, neurological outcome, received treatments and healthcare-associated costs

  Age < 75 (n = 1073) Age ≥75 (n = 212) p
Cost of treatments in €, median (IQR)    
 Hospital costs 29 971 (13 381 − 50 212) 18 356 (9 740 − 37 102) < 0.001
 Rehabilitation 0 (0–6 543) 0 (0–7 574) 0.928
 Social Insurance Institution 1 669 (579-6 686) 714 (392-1 760) < 0.001
Cost of treatment of those with CPC 1–2 after 12 months in €, median (IQR) (57 %)    
 Hospital 41 194 (27 031–63 709) 34 888 (19 083 − 60 029) 0.071
 Rehabilitation 2113 (0–9 603) 6073 (417 − 13 319) 0.012
 Social Insurance Institution 4 561 (1 173 − 15 043) 2 049 (1 196-3 509) < 0.001
Total cost in €, median (IQR)    
 Everyone 38 195 (16 505-71680) 22 641 (12 488 − 47 006) < 0.001
 Those with CPC 1–2 after 12 months (57) 54 510 (36 148 − 86 461) 39 482 (24 101 − 93 020) 0.040
Effective costa in €    
 Of those with CPC 1–2 after 12 months 119 941 168 416 -
Effective cost in € among those with CPC 1–2 after 12 months    
 OHCA 90 499 133 134 -
 IHCA 161 670 199 540 -
 ICUCA 308 000 172 595 -
  1. aEffective cost: The total healthcare-associated costs of all patients within their respective age group divided by the number of survivors with a favourable neurological outcome